Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer

Belle, Hannah Van; Hurvitz, Sara A.; Gilbar, Peter J; Wildiers, Hans

doi:10.1007/s10549-021-06387-1

Cited by 5 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The questionnaire was designed with reference to the Chinese Society of Clinical Oncology (CSCO) Guidelines on the Standardized Management of Radiotherapy and Chemoradiotherapy-related Neutropenia (2021) and previous literature [14][15][16]. The questionnaire design underwent two rounds of expert review.…”

Section: Questionnairementioning

confidence: 99%

Knowledge, attitude, and practice toward chemotherapy-related neutropenia and febrile neutropenia among breast cancer patients Running title: KAP of chemotherapy neutropenia in breast cancer

Chen,

Zhou,

Jiang

2023

Preprint

View full text Add to dashboard Cite

Aims This study aimed to investigate the knowledge, attitude, and practice (KAP) toward chemotherapy-related neutropenia and febrile neutropenia (FN) among breast cancer patients. Materials and methods A multi-center cross-sectional study enrolled breast cancer chemotherapy patients at four hospitals between April and June 2023. A self-administered questionnaire was developed to assess KAP scores. The structural equation model (SEM) was used to analyze the interactions between patients' knowledge and attitude and demographic characteristics. Results A total of 246 patients completed the questionnaire. The mean knowledge score was 12.46 ± 6.21 (possible range: 0–26) and the mean attitude score was 30.00 ± 2.58 (possible range: 7–35). Less than half of the patients knew whether their chemotherapy protocol was a high-risk protocol for FN (45.95%). However, the majority of patients were aware of the need for the prophylactic administration of leukocyte-raising agents (79.67%). Multivariate logistic regression analysis showed that junior college and above (OR = 4.69, 95% CI = 2.23–9.89, P < 0.001) was associated with adequate knowledge. Living in urban areas (OR = 0.58, 95% CI = 0.34–0.97, P = 0.037) was associated with positive attitude. The SEM showed that experience with chemotherapy-related neutropenia or FN had a direct effect on knowledge (β = 1.77, p = 0.029). Conclusion This study found inadequate knowledge, positive attitude and suboptimal practice toward chemotherapy-related neutropenia and FN among breast cancer chemotherapy patients. Tailored and effective education programs need to be designed and implemented to improve relevant KAP in this patient population.

show abstract

Section: Questionnairementioning

confidence: 99%